Lizbeth Anne Littlewood
Fondateur chez Ixchelsis Ltd.
Postes actifs de Lizbeth Anne Littlewood
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ixchelsis Ltd.
 Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Directeur des opérations | 27/07/2011 | - |
| Fondateur | 27/07/2011 | - |
Historique de carrière de Lizbeth Anne Littlewood
Formation de Lizbeth Anne Littlewood
| Sheffield Hallam University | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ixchelsis Ltd.
Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Lizbeth Anne Littlewood
- Expérience
